Tobacco company Philip Morris International (PMI) is raising eyebrows as it edges ever closer to its acquisition of UK inhaler maker Vectura and investment experts are divided about the future of the company from an ESG perspective.
"If one was cynical, one could say this is a move to greenwash over the less desirable areas of the business," said Miranda Beacham, head of ESG for equities & multi asset at Aegon AM. Whether one is cynical or not, when considering the big picture, Chris Beckett, equity analyst at Quilter Cheviot, said the deal "does not change very much". It is quite small in comparison to the overall company, at around $1bn, while Philip Morris' market cap is around $156bn. However, Beckett added that "where it does make a difference is the intention of the company". Smoke-free products accou...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
